GILD vs MAX · P/E 18, rev $29.44B vs P/E 36, rev $864.7M
Gilead Sciences Inc (GILD) versus MediaAlpha Inc. (MAX) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
MediaAlpha Inc. (MAX) is a internet content & information company listed on US.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported MAX revenue for 2024-12-31 was $864.7M. Net income was $22.1M. Revenue was up 122.8% from 2023-12-31 to 2024-12-31. MAX currently screens at market cap $689.0M and trailing P/E 36.2.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. MAX currently screens at market cap $689.0M and trailing P/E 36.2.
Not investment advice. Open the GILD and MAX stock pages for the full models.
Not investment advice.